COVID-19 Request Received

Thank you for getting in touch with us regarding your interest in COVID-19 biosamples. Our team will be in touch as soon as possible.

We remain committed to doing everything we can to support ongoing research in this area, and we appreciate your feedback and participation as we work to deliver the critical research materials you need. Thank you for allowing us to be part of the work you do!

Your source for all 
things biotech

Stay informed with our expert insights, industry news, and groundbreaking discoveries.

Innovative Research Human Plasma Used in Cancer Study
Innovative Research Human Plasma Used in Cancer Study
News

Innovative Research Human Plasma Used in Cancer Study

Below is a reference from ScienceDirect.com regarding Innovative Research Human Plasma being used in a recent Cancer Study.You may need...

News

Immune modulation could explain how experimental Alzheimer's therapy works

In a July 8, 2013 press release, researchers at the University of Kentucky Sanders-Brown Center on Aging, led by Donna...

News

NCATS Eyes Changes to CTSA as Sequestration Limits Options

The complete article can be found through Genetic Engineering and Biotechnology News. NIH says it will improve its Clinical and...

News

DiaTech Oncology Receives New York State Clinical Laboratory Permit

From the June 25, 2013 press release: DiaTech Oncology, a life sciences and clinical pathology laboratory company based in Nashville,...

News

Human and Canine Lymphomas Share Molecular Similarities, First Large-Scale Comparison Shows

Taken from the Science Daily article. Humans and their pet dogs are close, so close that they both develop a...